MAHLY (Medipal Holdings) Moat Score: 6/10 (As of Jul. 09, 2026)


MAHLY Medipal Holdings Corp MAHLY
81 GF Score
Price $17.00
GF Value $16.37
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is Medipal Holdings Moat Score?

Medipal Holdings MAHLY 81 Moat Score is 6 as of Jul. 09, 2026. GuruFocus rates MAHLY with a GF Score™ of 81/100 and a GF Value™ of $16.37 (Fairly Valued). The stock has 1 warning sign investors should review. Among 119 Medical Distribution companies, Medipal Holdings ranks better than 97.48% on this metric.

Medipal Holdings has the Moat Score of 6, which implies that the company might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Medipal Holdings has Narrow Moat: Medipal Holdings Corp has a strong narrow moat due to its established distribution network in pharmaceuticals and medical supplies. It benefits from economies of scale and some customer loyalty. However, it lacks significant intellectual property or regulatory barriers to elevate it to a wide moat.

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Medipal Holdings might have Narrow Moat - Strong narrow moat, clearly distinguishable but not wide.

Medipal Holdings  (OTCPK:MAHLY) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Medipal Holdings Moat Score Related Terms

MAHLY vs MCK, CAH, COR: Moat Score Comparison

For the Medical Distribution subindustry, Medipal Holdings's Moat Score, along with its competitors' market caps and Moat Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medipal Holdings Moat Score vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Medipal Holdings's Moat Score distribution charts can be found below:

* The bar in red indicates where Medipal Holdings's Moat Score falls into.


MAHLY
81GF Score
Medipal Holdings Corp MAHLY
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Moat Score →
What does a Moat Score of 6 mean?
Medipal Holdings (MAHLY) has a Moat Score of 6 as of Jul. 09, 2026. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. According to the industry distribution chart, Medipal Holdings ranks #3 out of 119 companies in the Medical Distribution industry, placing it in the top 2.5%.
Is Medipal Holdings' Moat Score too high?
Medipal Holdings' current Moat Score is 6. Based on the distribution chart, Medipal Holdings ranks #3 out of 119 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Medipal Holdings has a GF Score™ of 81/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Medipal Holdings' Moat Score compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Medipal Holdings ranks #3 out of 119 companies for Moat Score. This places Medipal Holdings in the top 3% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Moat Score for a Medical Distribution company?
A good Moat Score depends on the Medical Distribution industry context. However, Moat Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Moat Score mean?
A high Moat Score can signal that a stock is expensive relative to its fundamentals. Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more. Medipal Holdings's current Moat Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medipal Holdings stock overvalued right now?
Based on GuruFocus' analysis, Medipal Holdings (MAHLY) is currently considered Fairly Valued. The stock's GF Value™ is $16.37, compared to a current price of $17.00 — trading 3.8% above its estimated fair value. The current Moat Score is 6. Medipal Holdings' overall GF Score™ is 81/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Moat Score calculated?
Moat Score is calculated from a company's financial statements. For Medipal Holdings (MAHLY), the current Moat Score is 6 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medipal Holdings (MAHLY) Overvalued in 2026?

Based on GuruFocus' analysis, Medipal Holdings stock appears to be overvalued. The current stock price of $17.00 is trading 3.8% above its estimated GF Value™ of $16.37. GuruFocus considers Medipal Holdings to be Fairly Valued.

Key valuation signals for MAHLY:

  • Moat Score: 6
  • GF Value™: $16.37 vs. price of $17.00 (3.8% above fair value)
  • GF Score™: 81/100 with 1 warning sign

No single metric tells the full story. See the MAHLY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medipal Holdings Business Description

Other Exchanges MEPDF:USA7459:Japan
Address 3-1-1 Kyobashi, Chuo-ku, Tokyo, JPN, 104-8461
Medipal Holdings Corp is engaged in the wholesale distribution of pharmaceuticals, cosmetics, daily necessities, and related products. The company operates through three reportable segments: Wholesale business of medical drugs; Cosmetics, Daily Necessities and OTC Pharmaceuticals Wholesale Business; and Wholesale of animal medicines and food processing ingredients. The Wholesale business of medical drugs segment targets hospitals, clinics, and dispensing pharmacies; the Cosmetics and OTC segment serves drug stores, home centers, convenience stores, and supermarkets; while the Wholesale of animal medicines and food processing ingredients segment supplies veterinary clinics, livestock and fisheries businesses, and food manufacturers.
81GF Score

Get the complete analysis for MAHLY

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$17.00
Price
$16.37
GF Value